JNJ

SELL

Johnson & Johnson

Healthcare · Rank #263 · Analyzed Apr 20, 2026

$234.18

Current Price

$249.09

Intrinsic Value

+61.6%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 61.6%

Fair Value Range

Low$27.08

Base (IV)$249.09

High$378.35

Entry Points

Conservative$27.08

Moderate$138.09

Aggressive$249.09

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 60 → 0/1.0

Revenue QualityGrowth 10.1%, margin Δ-12.0% → 0.5/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins21.8% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.